The latest teaser pitch from Jeff Brown has gotten a lot of attention from Gumshoe readers… so let’s dig in and get some answers (and yes, some readers already posted their findings in our discussions area… so we’ll see if they got the right answer). The ad is all about a microcap biotech stock that […]
Articles
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Elsewhere the sky is the roof of the […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. You can see his biography, previous columns and most recent comments on his Stock Gumshoe page.] “We ran the race, the race […]
[ed. note: This article originally ran on October 6, 2015. The ad is circulating again and generating questions here at Stock Gumshoe, and it appears unchanged. The article that follows is also unchanged and has not been updated. The stock being teased by Money Morning is essentially unchanged in price from when this article was […]
[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars! You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions.] If you get infected with CRE in your blood, your lungs, your urine, or your biliary system, what is your chance of […]
We’ve got a good teaser to solve today, but first — a quick plea: This will be our final week of “Gumshoe Gives Back” this year — we will be donating at least half of all the membership contributions received through the rest of this week (until the end of the day on Friday, 12/12) […]
Special Update on Cellceutix[ed. note: Dr. KSS writes about biotech stocks for the Irregulars. He has agreed to our trading restrictions, but he chooses his own topics and his words and thoughts are his own] According to new SEC filings, Cellceutix President, co-founder and Chief Scientific Officer Krishna Menon has recently settled what should probably be regarded as […]
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
[ed note: This is the latest in a series of articles from medical writer “Doc Gumshoe” (who, yes, is not actually a doctor) — it’s on the hot topic if antibiotic resistance, and we’ll likely continue to see companies touted and teased that aim to either fight resistant bacteria or clean up hospitals to slow […]
Mark Skousen, who is one of those Ph.D-type doctors (economics) and thankfully doesn’t always insist on being called Dr. Skousen (yes, we’re looking at you Dr. Leeb), is pitching a health care stock today as a teaser for his Forecasts and Strategies newsletter. And like some folks we’ve heard from in the past, he’s teasing […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
This must have come out literally right after I asked this question? Just found it. So glad I joined StockGumshoe! Goo...
I saw the same presentation regarding “5 Elite U.S. Stocks Set to Explode.” The e-mail made it sound like we would g...
A fairly new one that might do pretty well: $IVITF or $GENE in Canada. Also I am thinking $VPRB will do well though I wo...
10 risky nut rewarding stocks ro buy from #InvestorPlace https://investorplace.com/2018/01/risky-rewarding-small-cap-st...
Guess maybe I should have read the comments before subscribing to Slingshot Trader. As mentioned, this is just one of a...
I got one via InvestorPlace Special Offers. I listened to most of the spiel, but I don't have the funds to tap into the ...
PIRS-For more Form 4's filed 20K shares each: http://ir.pieris.com/all-sec-filings Tipranks.com : Analyst Name Firm ...
I see slingshot is not being advertised under investorplace which is a mass marketer. I feel that many sites that have...
Having read both the original court verdict and the appellate court decision upholding the guilty verdict against Stansb...
I joined...without searching internet. Looked at their track record...which they're stupid enough to post. Lost in 201...
I am glad I found this set of reviews for John Lansing ("JL" as he likes to be called) and his Trending123 Service. I ...
Without urgency, they can't convince you to subscribe! The Investorplace folks have a variety of ...
The way the service is marketing itself can tell you a lot about it. This service gives you a GUARANTEE of 50% gains per...
thanks dlst, my blog was shut down. I imagine the guys at investorplace got upset......
I have to agree with all the comments here, my time viewing the site was terrible, and yes I did suffer some losses, but...
I keep getting emails from John Lansing at options zone. At the bottom it tells us that it is sent from InvestorPlace. ...
Jamie and I had newsletters at the same time at InvestorPlace. He started with Al Frank of the Prudent Speculator, then...
And like Bryan Perry (25% Cash Machine...also Investorplace) she likes BDC's ...but is this superior to (AINV)?...
Good comment -- at one point one of the China investment newsletters (Cabot's, not Hsu's) was actually the best performi...
Been seeing this a bit more from Investorplace (Hsu and Navellier, at least), teaser stocks being touted in ads after th...
I agree that registering for the Portfolio Grader opens you up to a considerable e-mail from Louis but the hotlist secti...
I suppose you never know, but I'd be surprised. And of course, it's not Navellier himself doing this marketing, it's In...